Zai Lab Limited today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates. "Zai Lab is entering the next phase of our growth, powered ...

PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation initiated, with initial data expected in H1 2026 WELLESLEY ...

The final, formatted version of the article will be published soon. Background: Infantile hemangioma (IH), the most common vascular tumor of infancy, exhibits hallmark features of immune and ...

Description of Case: A 62-year-old male with a past medical history of chronic kidney disease stage 4, hyperlipidemia, and lacunar stroke presented with a 1-month history of worsening painless ...

Abstract: For many actual distribution systems, an accurate system model might not be available, so the operator has to fit an approximate power flow model over a set of field measurements. To ...